HTG Molecular Diagnostics, Inc. (HTGMQ)

OTCMKTS: HTGMQ · Delayed Price · USD
0.0015
0.00 (0.00%)
Mar 27, 2024, 10:08 AM EDT - Market open
Market Cap 3.32K
Revenue (ttm) 3.47M
Net Income (ttm) -9.75M
Shares Out 2.21M
EPS (ttm) -6.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 543
Open 0.0015
Previous Close 0.0015
Day's Range 0.0015 - 0.0015
52-Week Range 0.0010 - 4.7700
Beta 3.05
Analysts n/a
Price Target n/a
Earnings Date n/a

About HTGMQ

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company dist... [Read more]

Sector Healthcare
IPO Date May 6, 2015
Employees 53
Stock Exchange OTCMKTS
Ticker Symbol HTGMQ
Full Company Profile

Financial Performance

In 2022, HTGMQ's revenue was $6.37 million, a decrease of -28.52% compared to the previous year's $8.91 million. Losses were -$21.59 million, 26.0% more than in 2021.

Financial Statements

News

HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention

TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its managemen...

11 months ago - GlobeNewsWire

HTG Highlights the Advantages of Its Drug Discovery Engine

TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of anot...

11 months ago - GlobeNewsWire

HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights

TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results f...

11 months ago - GlobeNewsWire

HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19

TUCSON, Ariz., April 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced there will be at...

1 year ago - GlobeNewsWire

HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event

TUCSON, Ariz., Jan. 09, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Announces Certain Preliminary 2022 Unaudited Financial Results

Preliminary full year 2022 unaudited revenue of $6.4 million

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series

TUCSON, Ariz., Dec. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering

TUCSON, Ariz., Dec. 23, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics Announces Pricing of a $10 Million Public Offering

TUCSON, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Announces One-for-Twelve Reverse Stock Split

TUCSON, Ariz., Dec. 20, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series

TUCSON, Ariz., Dec. 09, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Technology Featured Across Numerous Abstracts at Upcoming Scientific Conferences

TUCSON, Ariz., Dec. 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics Reports Third Quarter 2022 Results

TUCSON, Ariz., Nov. 10, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG to Collaborate With OmiCure, Providing Transcriptomic Data Across Several Cancer Indications

TUCSON, Ariz. and PARIS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptom...

1 year ago - GlobeNewsWire

HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz., Oct. 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference

TUCSON, Ariz., Sept. 26, 2022 (GLOBE NEWSWIRE) --  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide p...

1 year ago - GlobeNewsWire

The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test

TUCSON, Ariz., Sept. 20, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pr...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11

TUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition

TUCSON, Ariz., July 19, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility

TUCSON, Ariz., July 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz., July 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer

TUCSON, Ariz., June 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG to Sponsor Keynote Presentation Featuring Customer Use of its HTG EdgeSeq Technology in Clinical Trials

TUCSON, Ariz., June 08, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022

TUCSON, Ariz., June 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide pro...

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference

TUCSON, Ariz., May 17, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide prof...

2 years ago - GlobeNewsWire